A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
Clinical trial NCT07183306 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07183306
- Sponsor
- Suzhou HepaThera Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-08-24
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.